Certain AML genetic abnormalities, like t(8;21), inv(16) and t(9;11), mutations in NPM1, NRAS, and DNMT3A, are associated with a higher incidence of extramedullary disease [1, 3, 5, 23]. This evidence concerns the gene NRAS and acute myeloid leukemia.